Semler Scientific (NASDAQ:SMLR) Shares Down 5.6% – What’s Next?

Semler Scientific, Inc. (NASDAQ:SMLR) shares traded down 5.6% during mid-day trading on Friday . The company traded as low as $67.33 and last traded at $67.82. 586,094 shares were traded during mid-day trading, an increase of 108% from the average session volume of 281,545 shares. The stock had previously closed at $71.84.

Semler Scientific Stock Down 6.5 %

The company’s 50-day moving average is $43.82 and its 200-day moving average is $34.79. The stock has a market capitalization of $556.77 million, a price-to-earnings ratio of 32.77 and a beta of 1.18.

Semler Scientific (NASDAQ:SMLR) last announced its quarterly earnings results on Monday, November 4th. The company reported $0.72 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.35. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%. The business had revenue of $13.51 million during the quarter.

Hedge Funds Weigh In On Semler Scientific

A number of hedge funds have recently modified their holdings of the business. State Street Corp lifted its position in Semler Scientific by 0.6% in the third quarter. State Street Corp now owns 118,223 shares of the company’s stock valued at $2,784,000 after buying an additional 725 shares during the last quarter. CWM LLC boosted its position in shares of Semler Scientific by 486.3% during the 2nd quarter. CWM LLC now owns 897 shares of the company’s stock worth $31,000 after purchasing an additional 744 shares during the period. Quest Partners LLC boosted its position in shares of Semler Scientific by 48.0% during the 3rd quarter. Quest Partners LLC now owns 2,520 shares of the company’s stock worth $59,000 after purchasing an additional 817 shares during the period. Newbridge Financial Services Group Inc. acquired a new stake in Semler Scientific in the 2nd quarter valued at approximately $34,000. Finally, US Bancorp DE raised its position in Semler Scientific by 60.8% in the third quarter. US Bancorp DE now owns 3,064 shares of the company’s stock valued at $72,000 after purchasing an additional 1,158 shares during the period. 49.37% of the stock is currently owned by hedge funds and other institutional investors.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.